Understanding and diagnosing the potential for bias when using machine learning methods with doubly robust causal estimators.


Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 3 5 2018
medline: 28 7 2020
entrez: 3 5 2018
Statut: ppublish

Résumé

Data-adaptive methods have been proposed to estimate nuisance parameters when using doubly robust semiparametric methods for estimating marginal causal effects. However, in the presence of near practical positivity violations, these methods can produce a separation of the two exposure groups in terms of propensity score densities which can lead to biased estimates of the treatment effect. To motivate the problem, we evaluated the Targeted Minimum Loss-based Estimation procedure using a simulation scenario to estimate the average treatment effect. We highlight the divergence in estimates obtained when using parametric and data-adaptive methods to estimate the propensity score. We then adapted an existing diagnostic tool based on a bootstrap resampling of the subjects and simulation of the outcome data in order to show that the estimation using data-adaptive methods for the propensity score in this study may lead to large bias and poor coverage. The adapted bootstrap procedure is able to identify this instability and can be used as a diagnostic tool.

Identifiants

pubmed: 29717941
doi: 10.1177/0962280218772065
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1637-1650

Subventions

Organisme : CIHR
Pays : Canada

Auteurs

Asma Bahamyirou (A)

1 Faculté de pharmacie, Université de Montréal, Montréal, Canada.

Lucie Blais (L)

1 Faculté de pharmacie, Université de Montréal, Montréal, Canada.

Amélie Forget (A)

1 Faculté de pharmacie, Université de Montréal, Montréal, Canada.
2 Research Center, Hôpital du sacré-coeur de, Montréal, Canada.

Mireille E Schnitzer (ME)

1 Faculté de pharmacie, Université de Montréal, Montréal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH